期刊文献+

羟基喜树碱联合免疫增强剂治疗癌性腹水 被引量:1

Treatment of cancerous ascites with hydroxycamptothecin combined with immune preparation
原文传递
导出
摘要 目的 评价羟基喜树碱 (HCPT )联合免疫增强剂治疗癌性腹水的临床疗效。方法 将 78例癌性腹水病人分组行羟基喜树碱或羟基喜树碱联合免疫增强剂的腹腔化疗 ,并行空白对照 ,对其化疗后的腹水量及癌细胞数进行统计分析。结果 羟基喜树碱或羟基喜树碱联合免疫增强剂两组的腹水量与癌细胞数与对照组对比有显著差异。 Objective To evlauate the cli ni cal effect of hydroxycamptothecin(HCPT) combined with immune preparation on canc erous ascites.Methods Seventy eight patients with cancerous as citic fluid were divided into three groups.Group A were treated with HCPT,group B were treated with HCPT and immunocytokines,group C was control.The cancer cell and the volume of ascites in each group were analyzed.Results The number of cancer cells and the volume of ascites in group A and group B were lower than those in group C.The statistical difference was significant. Conclusion Combined HCPT and immunocytokines is an effective way to can cerous ascitic fluid.
作者 吴常青
出处 《中国基层医药》 CAS 2004年第1期44-45,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 羟基喜树碱 联合用药 免疫增强剂 药物治疗 癌性腹水 HCPT Immunocytokines Cancerous ascites
  • 相关文献

参考文献4

二级参考文献8

共引文献79

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部